Anemia, nonspherocytic hemolytic, due to G6PD deficiency: genes and variants
Explore variant evidence for Anemia, nonspherocytic hemolytic, due to G6PD deficiency across 1 analyzed protein (G6PD). Linked ClinVar records include 182 pathogenic or likely pathogenic variants, 78 variants of uncertain significance and 30 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Anemia, nonspherocytic hemolytic, due to G6PD deficiency
G6PD: Glucose-6-phosphate 1-dehydrogenase
It generates NADPH through the pentose-phosphate pathway, providing red blood cells with the reducing power needed to withstand oxidative stress. Deficiency can trigger neonatal jaundice or acute hemolytic anemia after infections, fava beans, or oxidant drugs.
182 ClinVar pathogenic / likely pathogenic and 108 uncertain variants in G6PD have source records linked to Anemia, nonspherocytic hemolytic, due to G6PD deficiency. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CASK.
ClinVar pathogenic and likely pathogenic variants linked to Anemia, nonspherocytic hemolytic, due to G6PD deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| G6PD A44G | 44 | Pathogenic / likely pathogenic (★★) | |
| G6PD G163S | 163 | Pathogenic / likely pathogenic (★★) | |
| G6PD R166H | 166 | Pathogenic / likely pathogenic (★★) | |
| G6PD R166C | 166 | Pathogenic / likely pathogenic (★★) | |
| G6PD R198C | 198 | Pathogenic / likely pathogenic (★★) | |
| G6PD R198H | 198 | Pathogenic / likely pathogenic (★★) | |
| G6PD R227W | 227 | Pathogenic / likely pathogenic (★★) | |
| G6PD D282H | 282 | Pathogenic / likely pathogenic (★★) | |
| G6PD R285H | 285 | Pathogenic / likely pathogenic (★★) | |
| G6PD G351E | 351 | Pathogenic / likely pathogenic (★★) | |
| G6PD R387H | 387 | Pathogenic / likely pathogenic (★★) | |
| G6PD R454H | 454 | Pathogenic / likely pathogenic (★★) | |
| G6PD R459P | 459 | Pathogenic / likely pathogenic (★★) | |
| G6PD R463C | 463 | Pathogenic / likely pathogenic (★★) | |
| G6PD H155D | 155 | Pathogenic / likely pathogenic (★★) | |
| G6PD S278F | 278 | Pathogenic / likely pathogenic (★★) | |
| G6PD G321E | 321 | Pathogenic / likely pathogenic (★★) | |
| G6PD A335D | 335 | Pathogenic / likely pathogenic (★★) | |
| G6PD A361V | 361 | Pathogenic / likely pathogenic (★★) | |
| G6PD I380T | 380 | Pathogenic / likely pathogenic (★★) | |
| G6PD C385R | 385 | Pathogenic / likely pathogenic (★★) | |
| G6PD C385F | 385 | Pathogenic / likely pathogenic (★★) | |
| G6PD R387C | 387 | Pathogenic / likely pathogenic (★★) | |
| G6PD R393C | 393 | Pathogenic / likely pathogenic (★★) | |
| G6PD R393H | 393 | Pathogenic / likely pathogenic (★★) | |
| G6PD E398K | 398 | Pathogenic / likely pathogenic (★★) | |
| G6PD G410A | 410 | Pathogenic / likely pathogenic (★★) | |
| G6PD G410C | 410 | Pathogenic / likely pathogenic (★★) | |
| G6PD G447R | 447 | Pathogenic / likely pathogenic (★★) | |
| G6PD R454P | 454 | Pathogenic / likely pathogenic (★★) | |
| G6PD R463S | 463 | Pathogenic / likely pathogenic (★★) | |
| G6PD H32R | 32 | Pathogenic / likely pathogenic (★★) | |
| G6PD P50S | 50 | Pathogenic / likely pathogenic (★★) | |
| G6PD V68M | 68 | Pathogenic / likely pathogenic (★★) | |
| G6PD R136C | 136 | Pathogenic / likely pathogenic (★★) | |
| G6PD F173L | 173 | Pathogenic / likely pathogenic (★★) | |
| G6PD I199V | 199 | Pathogenic / likely pathogenic (★★) | |
| G6PD V291M | 291 | Pathogenic / likely pathogenic (★★) | |
| G6PD L323P | 323 | Pathogenic / likely pathogenic (★★) | |
| G6PD A335V | 335 | Pathogenic / likely pathogenic (★★) | |
| G6PD P353S | 353 | Pathogenic / likely pathogenic (★★) | |
| G6PD R365H | 365 | Pathogenic / likely pathogenic (★★) | |
| G6PD H451Y | 451 | Pathogenic / likely pathogenic (★★) | |
| G6PD A44T | 44 | Pathogenic / likely pathogenic (★★) | |
| G6PD N165D | 165 | Pathogenic / likely pathogenic (★★) | |
| G6PD S332F | 332 | Pathogenic / likely pathogenic (★★) | |
| G6PD N363K | 363 | Pathogenic / likely pathogenic (★★) | |
| G6PD P396A | 396 | Pathogenic / likely pathogenic (★★) | |
| G6PD V453E | 453 | Pathogenic / likely pathogenic (★★) | |
| G6PD R459G | 459 | Pathogenic / likely pathogenic (★★) | |
| G6PD I48T | 48 | Pathogenic / likely pathogenic (★★) | |
| G6PD Y70H | 70 | Pathogenic / likely pathogenic (★★) | |
| G6PD R81C | 81 | Pathogenic / likely pathogenic (★★) | |
| G6PD G131V | 131 | Pathogenic / likely pathogenic (★★) | |
| G6PD L137F | 137 | Pathogenic / likely pathogenic (★★) | |
| G6PD D181V | 181 | Pathogenic / likely pathogenic (★★) | |
| G6PD K386E | 386 | Pathogenic / likely pathogenic (★★) | |
| G6PD P467R | 467 | Pathogenic / likely pathogenic (★★) | |
| G6PD N126D | 126 | Pathogenic / likely pathogenic (★★) | |
| G6PD G204D | 204 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 182.
Uncertain variants prioritized for review in Anemia, nonspherocytic hemolytic, due to G6PD deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| G6PD R227Q | 227 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R227G at the same position is pathogenic; REVEL 0.869 | |
| G6PD R136H | 136 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R136C at the same position is pathogenic; REVEL 0.837 | |
| G6PD R439H | 439 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; R439C at the same position is pathogenic; REVEL 0.929 | |
| G6PD C158G | 158 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; C158Y at the same position is pathogenic; REVEL 0.837 |
Which prediction tools work for Anemia, nonspherocytic hemolytic, due to G6PD deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 77 out of 100
- SIFT: 76 out of 100
- PolyPhen-2: 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 70 out of 100
- CADD: 66 out of 100
- AlphaGenome (splicing): 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 40 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 38 out of 100
Diseases related to Anemia, nonspherocytic hemolytic, due to G6PD deficiency
- Malaria, also linked to G6PD
- G6PD deficiency, also linked to G6PD
Frequently asked questions
Which genes have records linked to Anemia, nonspherocytic hemolytic, due to G6PD deficiency?
This view contains 1 analyzed proteins: G6PD. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 182 pathogenic or likely pathogenic variants, 78 variants of uncertain significance and 30 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 306 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center